Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

With the demand for affordable health care rising across Ohio, health officials are cautioning that funding for free and ...

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to ...

Breathing should be effortless . But for millions, conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease) ...

Theravance Biopharma’s partner Viatris has received China's National Medical Products Administration (NMPA) approval for ...

In a major positive step for global respiratory health, Member States at the 78th World Health Assembly (WHA), held May 19–27 ...